Abstract
Traditional measurement of somatosensory evoked potentials (SEPs) depends on averaging of many recordings, which introduces loss of dynamic variability. Single trial extraction provides a new measurement of SEP latency variability for evaluation of the neurodynamic status of the somatosensory pathway. The aim of this study was to apply a single trial SEP to diagnose the severity of demyelination in a chronical spinal cord injury model. The severity of demyelination was measured by myelin area and staining intensity at the ventral column (VC), lateral column (LC), and dorsal column (DC) by histological examination with Luxol fast blue staining. Results showed that there was a strong negative correlation of the latency variability of trial-to-trial SEP with the myelin area in three columns (DC: r=-0.90, p<0.05; VC: r=-0.91, p<0.05; LC: r=-0.89, p<0.05), and the staining intensity in three columns (DC: r=-0.95, p<0.05; VC: r=-0.94, p<0.05; LC: r=-0.93, p<0.05). These data suggest that single trial SEP can provide a dynamic indicator of spinal cord demyelination.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
